May 17, 2023
NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions
“As the life sciences industry continues to evolve, we see increasing demand for quality properties to support companies across all stages of innovation...”

NexPoint, a multibillion-dollar alternative investment platform, today announced the acquisition of two life sciences industrial properties located in Philadelphia, Pennsylvania, from Frontida Biopharm, LLC, a company in the Adare Pharma Solutions group, which is a global technology-driven contract development and manufacturing organization focused on oral dosage forms for the pharmaceutical industry. The properties were indirectly acquired by NexPoint Life Sciences II DST, a Delaware statutory trust seeking to raise $42 million in equity from accredited investors via a private placement offering. NexPoint Life Sciences II DST aims to raise capital from investors looking for exposure to the growing life sciences real estate sector.

The real estate transaction builds on NexPoint’s commitment to grow its presence within the life sciences industry and to provide best-in-class facilities for innovative companies in the research, development, and manufacturing of pharmaceuticals, biotechnology-based food and medicines, medical devices, biomedical technologies, nutraceuticals, and cosmeceuticals.

The real estate acquisition includes nearly 18 acres of land across the two separate properties and more than 250,000 square feet of interior space where Frontida Biopharm, LLC will remain the tenant. The first property comprises R&D, production, and warehouse facilities capable of producing three billion tablets and capsules annually. The second property features distribution facilities and packaging capacity for four billion tablets and capsules annually and allows for potential expansion on its 12-acre campus.

“As the life sciences industry continues to evolve, we see increasing demand for quality properties to support companies across all stages of innovation,” said Matt McGraner, NexPoint Real Estate Advisors’ Chief Investment Officer. “We are committed to expanding our footprint in this critical sector with modern facilities that help life sciences companies do their best work.”

About NexPoint

NexPoint is a multibillion-dollar alternative investment firm comprised of a group of investment advisers and sponsors, a broker-dealer, and a suite of related investment vehicles. NexPoint provides differentiated access to alternatives through a range of investment solutions, including public and private real estate investment trusts, tax-advantaged real estate vehicles, merger arbitrage and event driven strategies, other private real estate investments, closed-end funds, interval funds, and a business development company. NexPoint is based in Dallas, Texas and is part of a network of affiliates with expertise across the asset management and financial services spaces. For more information visit nexpoint.com.

Important Disclosures

Only “accredited investors” (as that term is defined in Rule 501 promulgated under the Securities Act of 1933) who meet certain minimum requirements may invest. Investing in NexPoint Life Sciences II DST interests involves a high degree of risk. Past performance does not guarantee future results. Before investing, please review the applicable offering materials, including NexPoint Life Sciences II DST’s Confidential Private Placement Memorandum as amended or supplemented from time to time, including the “risk factors.”

Contacts

Media Relations
Mike Geller, Prosek Partners for NexPoint
mgeller@prosek.com

Investor Relations
Kristen Thomas, NexPoint
IR@nexpoint.com

Recent

Inland and University Partners Form Strategic Student Housing Relationship

Inland and University Partners Form Strategic Student Housing Relationship

“We are thrilled to work with University Partners, a proven leader and innovator in the student housing industry, as we continue to grow IPC’s platform with best-in-class, institutional quality student housing assets,” said Keith Lampi, president and chief executive officer of IPC.

Most Popular

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update 10-3-2023 Blue Vault wishes to acknowledge and apologize for the delay in publishing some Q2 2023 NTR Individual Performance Pages (IPPs) as well as the full review. We recently added additional reporting metrics to our IPPs, and that, combined with coverage of all share classes and some additional…
Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update

Blue Vault Q2 2023 Performance Reports Update 9-25-2023 Blue Vault has published the Q2 2023 Nontraded BDC Industry Review as well as Individual Performance Report and Limited Operations pages for the following offerings (newly published pages in bold font): Nontraded REITS American Healthcare REIT Q2 2023 Apollo Realty Income Solutions Q2 2023 (limited operations) Ares…

Explore

Blue Vault Logo
Don’t miss alts news
and educational events

Subscribe Now